Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
Carlsmed (Nasdaq: CARL) will report third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Participants should dial in 5–10 minutes early and can register via the provided participant registration link. A replay of the webcast will be available shortly after the call and will be archived on the company's investor website.
Carlsmed (Nasdaq: CARL) riferirà i risultati finanziari del terzo trimestre 2025 dopo la chiusura del mercato giovedi 6 novembre 2025. Il management terrà una conference call e una webcast in contemporanea a partire dalle 13:30 ora del Pacifico. I partecipanti dovranno chiamare 5–10 minuti prima e possono registrarsi tramite il link di registrazione fornito. Una replica della webcast sarà disponibile poco dopo la chiamata e sarà archiviata sul sito per gli investitori dell'azienda.
Carlsmed (Nasdaq: CARL) reportará los resultados financieros del tercer trimestre de 2025 después del cierre del mercado el jueves 6 de noviembre de 2025. La dirección celebrará una conferencia telefónica y una transmisión web simultánea a partir de las 1:30 PM hora del Pacífico. Los participantes deben llamar 5 a 10 minutos antes y pueden registrarse mediante el enlace de registro de participantes proporcionado. Una reproducción de la transmisión estará disponible poco después de la llamada y se archivará en el sitio web de inversores de la empresa.
Carlsmed (Nasdaq: CARL)는 2025년 3분기 실적을 2025년 11월 6일 목요일 장 마감 후 발표합니다. 경영진은 태평양 표준시 1:30 PM부터 컨퍼런스 콜과 동시 웹캐스트를 주최합니다. 참가자는 5–10분 먼저 전화로 연결해야 하며, 제공된 참가자 등록 링크를 통해 등록할 수 있습니다. 웹캐스트의 재생은 호출 직후에 이용 가능하며 기업의 투자자 웹사이트에 보관됩니다.
Carlsmed (Nasdaq : CARL) annoncera les résultats financiers du troisième trimestre 2025 après la clôture du marché, le jeudi 6 novembre 2025. La direction animera une conférence téléphonique et une webdiffusion simultanée à partir de 13h30, heure du Pacifique. Les participants doivent composer 5 à 10 minutes avant et peuvent s’inscrire via le lien d’inscription des participants fourni. Une rediffusion de la webdiffusion sera disponible peu après l’appel et sera archivée sur le site investisseurs de l’entreprise.
Carlsmed (Nasdaq: CARL) wird die Finanzergebnisse des dritten Quartals 2025 nach Börsenschluss am Donnerstag, dem 6. November 2025 bekannt geben. Die Geschäftsleitung wird ab 13:30 Uhr Pacific Time eine Telefonkonferenz und einen gleichzeitigen Webcast durchführen. Die Teilnehmer sollten 5–10 Minuten früher anrufen und sich über den bereitgestellten Link zur Registrierung anmelden. Eine Wiederholung des Webcasts wird kurz nach dem Anruf verfügbar sein und im Investorenseite des Unternehmens archiviert werden.
Carlsmed (Nasdaq: CARL) ستعلن عن النتائج المالية للربع الثالث من 2025 بعد إغلاق السوق يوم الخميس 6 نوفمبر 2025. ستستضيف الإدارة مكالمة مؤتمرات وبثًا إلكترونيًا متزامنًا ابتداء من الساعة 1:30 مساءً بتوقيت المحيط الهادئ. يُنصح المشاركون بالاتصال قبل 5–10 دقائق ويمكنهم التسجيل عبر الرابط المقدم لتسجيل المشاركين. سيكون هناك إعادة للبث بعد المكالمة وستُ/archive على موقع الشركة للمستثمرين.
Carlsmed (Nasdaq: CARL) 将在市场收盘后于 2025 年 11 月 6 日(星期四)公布 2025 年第三季度 的财务业绩。管理层将于 太平洋时间 1:30 PM 开始举行电话会议并同步进行网络广播。参与者请提前 5–10 分钟 拨入,并可通过提供的参与者注册链接进行注册。网络广播的回放将在电话会议结束后不久可用,并将归档在公司投资者网站上。
- None.
- None.
CARLSBAD, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
Conference Call Information
To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.
Event Date: Thursday, November 6, 2025
Time: 1:30 PM Pacific Time
Participant Registration: https://register-conf.media-server.com/register/BI1ecfe408f669412a83420306dedf3952
A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com